메뉴 건너뛰기




Volumn 6, Issue 1, 2011, Pages

Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CYBERKNIFE; FOLLOW UP; HUMAN; INSTRUMENTATION; KAPLAN MEIER METHOD; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM DISEASE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; BLOOD; CARCINOMA; DISEASE COURSE; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSTATE TUMOR; RADIATION INJURY; RADIOSURGERY; RISK; TIME;

EID: 78650982500     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-3     Document Type: Article
Times cited : (194)

References (35)
  • 1
    • 0032913909 scopus 로고    scopus 로고
    • Fractionation and protraction for radiotherapy of prostate carcinoma
    • 10.1016/S0360-3016(98)00438-6, 10192361
    • Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:1095-1101. 10.1016/S0360-3016(98)00438-6, 10192361.
    • (1999) Int J Radiat Oncol Biol Phys , vol.43 , pp. 1095-1101
    • Brenner, D.J.1    Hall, E.J.2
  • 2
    • 0038724753 scopus 로고    scopus 로고
    • What hypofractionated protocols should be tested for prostate cancer?
    • 10.1016/S0360-3016(03)00132-9, 12829147
    • Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 2003, 56:1093-1104. 10.1016/S0360-3016(03)00132-9, 12829147.
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 1093-1104
    • Fowler, J.F.1    Ritter, M.A.2    Chappell, R.J.3    Brenner, D.J.4
  • 3
    • 34248594934 scopus 로고    scopus 로고
    • Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?
    • Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?. Clin Oncol (R Coll Radiol) 2007, 19:289-301.
    • (2007) Clin Oncol (R Coll Radiol) , vol.19 , pp. 289-301
    • Dasu, A.1
  • 4
    • 73349139882 scopus 로고    scopus 로고
    • Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials
    • 10.1007/s12094-009-0382-2, 19574201
    • Macias V, Biete A. Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials. Clin Transl Oncol 2009, 11:437-445. 10.1007/s12094-009-0382-2, 19574201.
    • (2009) Clin Transl Oncol , vol.11 , pp. 437-445
    • Macias, V.1    Biete, A.2
  • 5
    • 1542267898 scopus 로고    scopus 로고
    • High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds
    • 10.1097/01.ju.0000113299.34404.22, 14767279
    • Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004, 171:1098-1104. 10.1097/01.ju.0000113299.34404.22, 14767279.
    • (2004) J Urol , vol.171 , pp. 1098-1104
    • Grills, I.S.1    Martinez, A.A.2    Hollander, M.3    Huang, R.4    Goldman, K.5    Chen, P.Y.6    Gustafson, G.S.7
  • 6
    • 78049478731 scopus 로고    scopus 로고
    • High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer
    • 10.1097/COC.0b013e3181b9cd2f, 19952715
    • Martinez AA, Demanes J, Vargas C, Schour L, Ghilezan M, Gustafson GS. High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer. Am J Clin Oncol 2010, 33(5):481-8. 10.1097/COC.0b013e3181b9cd2f, 19952715.
    • (2010) Am J Clin Oncol , vol.33 , Issue.5 , pp. 481-488
    • Martinez, A.A.1    Demanes, J.2    Vargas, C.3    Schour, L.4    Ghilezan, M.5    Gustafson, G.S.6
  • 8
    • 77952573123 scopus 로고    scopus 로고
    • CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance
    • 10.1089/end.2009.0438, 20433370
    • Aluwini S, van Rooij P, Hoogeman M, Bangma C, Kirkels WJ, Incrocci L, Kolkman-Deurloo IK. CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance. J Endourol 2010, 24:865-869. 10.1089/end.2009.0438, 20433370.
    • (2010) J Endourol , vol.24 , pp. 865-869
    • Aluwini, S.1    van Rooij, P.2    Hoogeman, M.3    Bangma, C.4    Kirkels, W.J.5    Incrocci, L.6    Kolkman-Deurloo, I.K.7
  • 10
    • 40949091902 scopus 로고    scopus 로고
    • Virtual HDR(SM) CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations
    • 10.1016/j.ijrobp.2007.11.067, 18374232
    • Fuller DB, Naitoh J, Lee C, Hardy S, Jin H. Virtual HDR(SM) CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations. Int J Radiat Oncol Biol Phys 2008, 70:1588-1597. 10.1016/j.ijrobp.2007.11.067, 18374232.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 1588-1597
    • Fuller, D.B.1    Naitoh, J.2    Lee, C.3    Hardy, S.4    Jin, H.5
  • 11
    • 77749338092 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for organ-confined prostate cancer
    • 10.1186/1471-2490-10-1, 2831888, 20122161
    • Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010, 10:1. 10.1186/1471-2490-10-1, 2831888, 20122161.
    • (2010) BMC Urol , vol.10 , pp. 1
    • Katz, A.J.1    Santoro, M.2    Ashley, R.3    Diblasio, F.4    Witten, M.5
  • 12
    • 61349144278 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    • 10.1016/j.ijrobp.2008.05.059, 18755555
    • King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73:1043-1048. 10.1016/j.ijrobp.2008.05.059, 18755555.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , pp. 1043-1048
    • King, C.R.1    Brooks, J.D.2    Gill, H.3    Pawlicki, T.4    Cotrutz, C.5    Presti, J.C.6
  • 13
    • 33847248003 scopus 로고    scopus 로고
    • Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results
    • 10.1016/j.ijrobp.2006.10.050, 17336216
    • Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007, 67:1099-1105. 10.1016/j.ijrobp.2006.10.050, 17336216.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 1099-1105
    • Madsen, B.L.1    Hsi, R.A.2    Pham, H.T.3    Fowler, J.F.4    Esagui, L.5    Corman, J.6
  • 15
    • 0025313292 scopus 로고
    • Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984)
    • 10.1016/0090-4295(90)80207-4, 2385876
    • Lloyd-Davies RW, Collins CD, Swan AV. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990, 36:107-111. 10.1016/0090-4295(90)80207-4, 2385876.
    • (1990) Urology , vol.36 , pp. 107-111
    • Lloyd-Davies, R.W.1    Collins, C.D.2    Swan, A.V.3
  • 16
    • 50449083967 scopus 로고    scopus 로고
    • Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT
    • 10.1118/1.2968333, 18841856
    • Hossain S, Xia P, Chuang C, Verhey L, Gottschalk AR, Mu G, Ma L. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 2008, 35:4041-4048. 10.1118/1.2968333, 18841856.
    • (2008) Med Phys , vol.35 , pp. 4041-4048
    • Hossain, S.1    Xia, P.2    Chuang, C.3    Verhey, L.4    Gottschalk, A.R.5    Mu, G.6    Ma, L.7
  • 17
    • 77955927836 scopus 로고    scopus 로고
    • Dose gradient gear target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer
    • Hossain S, Xia P, Huang K, Descovich M, Chuang C, Gottschalk AR, Roach M, Ma L. Dose gradient gear target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010,
    • (2010) Int J Radiat Oncol Biol Phys
    • Hossain, S.1    Xia, P.2    Huang, K.3    Descovich, M.4    Chuang, C.5    Gottschalk, A.R.6    Roach, M.7    Ma, L.8
  • 18
    • 49549093853 scopus 로고    scopus 로고
    • Intrafractional motion of the prostate during hypofractionated radiotherapy
    • 10.1016/j.ijrobp.2008.04.051, 2725181, 18722274
    • Xie Y, Djajaputra D, King CR, Hossain S, Ma L, Xing L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:236-246. 10.1016/j.ijrobp.2008.04.051, 2725181, 18722274.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 236-246
    • Xie, Y.1    Djajaputra, D.2    King, C.R.3    Hossain, S.4    Ma, L.5    Xing, L.6
  • 19
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
    • 10.1016/0360-3016(95)00060-C, 7713792
    • Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346. 10.1016/0360-3016(95)00060-C, 7713792.
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 20
    • 37449026934 scopus 로고    scopus 로고
    • The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
    • 10.1002/cncr.23139, 17968996
    • Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 2008, 112:55-60. 10.1002/cncr.23139, 17968996.
    • (2008) Cancer , vol.112 , pp. 55-60
    • Abramowitz, M.C.1    Li, T.2    Buyyounouski, M.K.3    Ross, E.4    Uzzo, R.G.5    Pollack, A.6    Horwitz, E.M.7
  • 22
  • 24
    • 0030758727 scopus 로고    scopus 로고
    • Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
    • 10.1016/S0360-3016(97)00123-5, 9240638
    • Keyser D, Kupelian PA, Zippe CD, Levin HS, Klein EA. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?. Int J Radiat Oncol Biol Phys 1997, 38:723-729. 10.1016/S0360-3016(97)00123-5, 9240638.
    • (1997) Int J Radiat Oncol Biol Phys , vol.38 , pp. 723-729
    • Keyser, D.1    Kupelian, P.A.2    Zippe, C.D.3    Levin, H.S.4    Klein, E.A.5
  • 25
    • 0346363495 scopus 로고    scopus 로고
    • Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
    • 10.1016/S0360-3016(03)00784-3, 14697417
    • Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58:25-33. 10.1016/S0360-3016(03)00784-3, 14697417.
    • (2004) Int J Radiat Oncol Biol Phys , vol.58 , pp. 25-33
    • Kupelian, P.A.1    Potters, L.2    Khuntia, D.3    Ciezki, J.P.4    Reddy, C.A.5    Reuther, A.M.6    Carlson, T.P.7    Klein, E.A.8
  • 26
    • 0034650685 scopus 로고    scopus 로고
    • A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution
    • 10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z, 10640977
    • Martinez AA, Gonzalez JA, Chung AK, Kestin LL, Balasubramaniam M, Diokno AC, Ziaja EL, Brabbins DS, Vicini FA. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution. Cancer 2000, 88:425-432. 10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z, 10640977.
    • (2000) Cancer , vol.88 , pp. 425-432
    • Martinez, A.A.1    Gonzalez, J.A.2    Chung, A.K.3    Kestin, L.L.4    Balasubramaniam, M.5    Diokno, A.C.6    Ziaja, E.L.7    Brabbins, D.S.8    Vicini, F.A.9
  • 27
    • 80755146969 scopus 로고    scopus 로고
    • Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
    • King CR, Brooks JD, Gill H, Presti JCJ. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010,
    • (2010) Int J Radiat Oncol Biol Phys
    • King, C.R.1    Brooks, J.D.2    Gill, H.3    Presti, J.C.J.4
  • 28
    • 70350515452 scopus 로고    scopus 로고
    • Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
    • 10.1016/j.radonc.2009.09.001, 19800702
    • Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 2009, 93:185-191. 10.1016/j.radonc.2009.09.001, 19800702.
    • (2009) Radiother Oncol , vol.93 , pp. 185-191
    • Aizer, A.A.1    Yu, J.B.2    Colberg, J.W.3    McKeon, A.M.4    Decker, R.H.5    Peschel, R.E.6
  • 31
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
    • 10.1016/S0094-0143(05)70163-4, 11590814
    • Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001, 28:555-565. 10.1016/S0094-0143(05)70163-4, 11590814.
    • (2001) Urol Clin North Am , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3    Epstein, J.I.4    Walsh, P.C.5
  • 32
    • 27744545777 scopus 로고    scopus 로고
    • Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes
    • 10.1016/j.ijrobp.2005.05.054, 16169683
    • Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005, 63:1463-1468. 10.1016/j.ijrobp.2005.05.054, 16169683.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , pp. 1463-1468
    • Kupelian, P.A.1    Thakkar, V.V.2    Khuntia, D.3    Reddy, C.A.4    Klein, E.A.5    Mahadevan, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.